Greenwald Earnings Power Value EPV Lecture Slides
Greenwald Earnings Power Value EPV Lecture Slides
Greenwald Earnings Power Value EPV Lecture Slides
and Valuation
1
Value Investing Principles
2
Value Investing Process
SEARCH
• Cheap
• Ugly
• Obscure
• Otherwise Ignored
VALUATION
• Assets
• Earnings Power
• Franchise
REVIEW
• Key Issues
• Collateral Evidence
• Personal Biases
RISK MANAGEMENT
• Margin of Safety
• Some Diversification
• Patience – Default
Strategy
3
4
Systematic Biases
1. Institutional
z Herding – Minimize Deviations
z Window Dressing (January Effect)
z Blockbusters
2. Individual
z Loss Aversion
z Hindsight Bias
z Lotteries
5
Value Investing Process
SEARCH
• Cheap
• Ugly
• Obscure
• Otherwise Ignored
VALUATION
• Assets
• Earnings Power
• Franchise
REVIEW
• Key Issues
• Collateral Evidence
• Personal Biases
RISK MANAGEMENT
• Margin of Safety
• Some Diversification
• Patience – Default
Strategy
6
Valuation Approaches – Ratio Analysis
• Leverage
EBIT - A
(Maint. Inv. = Depr only) • Mgmt. Quality
7
Valuation Approaches
Net Present Value of Cash Flow
∞
Σ CF (1 +1 R )
t
1
Value = t = CF0 *
t=0 R-g
In Practice:
Revenues
Parameters: Forces:
z Market Size z Consumer
Behavior
z Market Share Margins
z Competitor
z Market Growth
Behavior
z Price/Cost
Required z Cost Pressures
z Tech Investments z Technology
z Management
z Tech
Performance
Cash Flows z Management
Performance
Cost of Capital X
NPV </> Market Value
8
Shortcomings of NPV Approach in
Practice
(1) Method of Combining Information
20
1 1
NPV = CFo +CF1 + … +CF20 + ...
1+R 1+R
Good
Bad Information
Information
(Imprecise)
(Precise)
= Bad/Imprecise Information
Cost of
Capital
Profit Required
Margin Investment
Growth
9
Valuation Assumptions
Traditional: Strategic:
10
Value Investing
Basic Approach to Valuation
11
Basic Elements of Value
Strategic Dimension
Franchise Value
Current Competitive Advantage
Free Entry
No Competitive
Advantage
12
Industry Entry - Exit
13
Asset Value
Assets Basic Graham- Reproduction
Dodd Value Value
Cash Book Book
Accounts Receivable Book Book + Allowance
Inventories Book Book + LIFO
PPE 0 Orig Cost ± Adj
Product Portfolio 0 Years R & D
Customer Relationships0 Years SGA
Organization 0
Licenses, Franchises 0 Private Mkt. Value
Subsidiaries 0 Private Mkt. Value
Liabilities
A/P, AT, AL Book Book
Debt Book Fair Market
Def Tax, Reserves Book DCF
14
Earning Power Value
z Measurement
1
- Earnings Power Value = “Earnings” * Cost of capital
z Calculation
–“Earnings” – Accounting Income + Adjustments
–Cost of Capital = WACC (Enterprise Value)
–Equity Value = Earnings Power Value – Debt.
z Assumption:
–Current profitability is sustainable
15
“Earning Power” Calculation
16
Earnings Power Value
17
Earning Power and Entry - Exit
Case C: Consequence of
Comp. Advantage
and/or Superior
Management
Asset Value EP Value
19
Value of Growth - Basic Forces At Work
1 1
I.E. CF0 * vs. CF0 *
R-G R
Growth Rate
WACC
No Growth CF0
20
Value of Growth
Quantitative Effects
21
Earning Power and Entry - Exit
Case C: Consequence of
Comp. Advantage
and/or Superior
Management
Asset Value EP Value
z Growth at a competitive
disadvantage destroys value
(AT&T in info processing)
23
Value Investing Process
SEARCH
• Cheap
• Ugly
• Obscure
• Otherwise Ignored
VALUATION
• Assets
• Earnings Power
• Franchise
REVIEW
• Key Issues
• Collateral Evidence
• Personal Biases
RISK MANAGEMENT
• Margin of Safety
• Some Diversification
• Patience – Default
Strategy
24
Consequences of Free Entry
Commodity Markets (Steel)
$/Q “Economic Profit”
AC
ROE (20%) > Cost
of Capital
Price Entry/Expansion
Supply Up, Price
Down
Q
Firm Position
(Efficient Producers)
$/Q
ROE = 12%
AC
No Entry
No Profit
Price
Q
Firm Position
25
Product Differentiation
Branding
(Profitability & Stability)
Budweiser
Harley-Davidson
26
Consequences of Free Entry
Differentiated Markets (Luxury Cars)
$/Q “Economic Profit”
AC
ROE (20%) > Cost
of Capital
Entry/Expansion
Demand for Firm
Demand Curve shifts left (Fewer
Q sales at each
Firm Position
Price)
ROE = 12%
$/Q
No Entry
AC No Profit
Demand
Curve
Q
Firm Position
27
Barriers to Entry
Incumbent Cost Advantage
$/Q
ACEntrant
ACIncumbent
Firm Position Q
28
Barriers to Entry
Incumbent Demand Advantage
$/Q
AC (Entrant, Incumbent)
DemandIncumbent
DemandEntrant
Firm Position Q
29
Barriers to Entry
Economies of Scale
Demand Demand (Entrant, Incumbent)
$/Q $/Q
AC
AC
Entrant Incumbent
Firm Position Q Firm Position Q
No advantage No advantage
30
Barriers to Entry
Economies of Scale
$/Q D-Incumbent
Loss Profit
Price (Both)
AC
D-Entrant
Sales Sales Q
Entrant Incumbent
31
Varieties of Competitive Advantage
Key to Sustainability
32
Competitive Advantage Strategy
Implications
Pharmaceuticals
33
Assessing Competitive Advantages/
B-to-E Strategy Formulation
-Enhancement
·Product Line Extension
·Increase Purchase Frequency
·Increase Complexity
·Accelerate Progress
·Emphasize Fixed vs. Variable
Cost Technology.
34
Procedure in Practice
(Dividend + Repurchase)
(GDP±)
35
Prospective Returns
US & India Markets
U.S. Market
(1)6% (1/PE) + 2% (inflation) = 8%
India Market
(1)4% (1/PE) + 5% (inflation) = 9%
Expected Return = 9%
36
Hindustan Unilever: Market Dominance
Source: Company website showing AC Nielsen – Quarter Ended Sept 2007 value shares
3737
Hindustan Unilever: Financial returns
Stock information
3838
Infosys: Performance
* Source: Value Line Data, and Italics show VL Estimate for 2007.
3939
Simple Examples Franchise Verification
40
Simple Examples
Franchise Verification
41
Calculated Growth Stock Returns
42
Appendix
43